RATIONALE: There is evidence demonstrating changes in dopamine (DA) transmission in the nucleus accumbens (NAc) related to contingent versus non-contingent drug administration. OBJECTIVES: The aim of this study was to evaluate basal and 3,4-methylenedioxymethamphetamine (MDMA)-stimulated DA levels in the NAc of mice that had previously received contingent and non-contingent infusions of MDMA. Contingent mice were trained to self-administer MDMA (0.125 mg/kg/infusion) in 2-h sessions for 10 days. Yoked mice received either MDMA at the same dose or saline. Forty-eight hours after the last MDMA or saline administration, DA levels were measured by in vivo microdialysis before and after an MDMA (10 mg/kg, i.p.) challenge. Binding of [(3)H]-mazindol and [(3)H]-citalopram was evaluated by autoradiography. RESULTS: Animals receiving MDMA infusions showed significantly lower basal DA levels than the yoked saline group. A reduced activation of DA was observed following MDMA in contingent mice with respect to both yoked MDMA and saline mice. No significant alterations in DA transporter or serotonin transporter were observed in the three groups of mice. CONCLUSIONS: These results suggest that prolonged exposure to MDMA in mice produces changes in basal DA levels after drug withdrawal and a decreased neurochemical response at the level of the mesolimbic DA reward pathway that is, in part, related to instrumental learning during self-administration.
RATIONALE: There is evidence demonstrating changes in dopamine (DA) transmission in the nucleus accumbens (NAc) related to contingent versus non-contingent drug administration. OBJECTIVES: The aim of this study was to evaluate basal and 3,4-methylenedioxymethamphetamine (MDMA)-stimulated DA levels in the NAc of mice that had previously received contingent and non-contingent infusions of MDMA. Contingent mice were trained to self-administer MDMA (0.125 mg/kg/infusion) in 2-h sessions for 10 days. Yoked mice received either MDMA at the same dose or saline. Forty-eight hours after the last MDMA or saline administration, DA levels were measured by in vivo microdialysis before and after an MDMA (10 mg/kg, i.p.) challenge. Binding of [(3)H]-mazindol and [(3)H]-citalopram was evaluated by autoradiography. RESULTS: Animals receiving MDMA infusions showed significantly lower basal DA levels than the yoked saline group. A reduced activation of DA was observed following MDMA in contingent mice with respect to both yoked MDMA and salinemice. No significant alterations in DA transporter or serotonin transporter were observed in the three groups of mice. CONCLUSIONS: These results suggest that prolonged exposure to MDMA in mice produces changes in basal DA levels after drug withdrawal and a decreased neurochemical response at the level of the mesolimbic DA reward pathway that is, in part, related to instrumental learning during self-administration.
Authors: R J Verkes; H J Gijsman; M S Pieters; R C Schoemaker; S de Visser; M Kuijpers; E J Pennings; D de Bruin; G Van de Wijngaart; J M Van Gerven; A F Cohen Journal: Psychopharmacology (Berl) Date: 2001-01-01 Impact factor: 4.530
Authors: Peter Olausson; J David Jentsch; Natalie Tronson; Rachel L Neve; Eric J Nestler; Jane R Taylor Journal: J Neurosci Date: 2006-09-06 Impact factor: 6.167
Authors: Susan Schenk; Lincoln Hely; Barbara Lake; Evangelene Daniela; David Gittings; Deborah C Mash Journal: Eur J Neurosci Date: 2007-11-14 Impact factor: 3.386
Authors: Kevin D Lominac; Arianne D Sacramento; Karen K Szumlinski; Tod E Kippin Journal: Neuropsychopharmacology Date: 2011-10-26 Impact factor: 7.853
Authors: Fair M Vassoler; Michelle L Oranges; Anika M Toorie; Elizabeth M Byrnes Journal: Pharmacol Biochem Behav Date: 2018-07-26 Impact factor: 3.533
Authors: Kyu Y O'Rourke; Jillienne C Touchette; Elizabeth C Hartell; Elizabeth J Bade; Anna M Lee Journal: Neuropharmacology Date: 2016-06-21 Impact factor: 5.250